Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a treatment for Waldenström ... and Exchange Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback